Key result
Anti-tuberculosis chemotherapy alone was effective in 30 of 41 patients with acute tuberculous pericarditis, while corticosteroids did not demonstrably reduce the risk of developing constriction.
Population
41 patients with acute tuberculous pericarditis and a separate series of 15 patients presenting with…
Design
Cohort
Authors
Loading...
Supports chemotherapy as primary therapy for most acute cases; leaves open corticosteroid role in preventing constriction pending RCTs.
Cohort (n=56)
No
Anti-tuberculosis chemotherapy is effective for most patients with acute tuberculous pericarditis, but constrictive pericarditis can develop early and does not appear to be prevented by corticosteroids.
Gooi et al. (1978) conducted a cohort in Tuberculous pericarditis (n=56). Anti-tuberculosis chemotherapy was evaluated on Clinical effectiveness and development of constrictive pericarditis. Anti-tuberculosis chemotherapy alone was effective in 30 of 41 patients with acute tuberculous pericarditis, while corticosteroids did not demonstrably reduce the risk of developing constriction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: